Table 4. Open in new tab Meta-analysis... | Oxford Academic

Table 4.

Open in new tab

Meta-analysis results for all three outcomes, shown separately for HD and non-HD patients

	All-cause mortality [RR (95% CI) (I₂)]		CVD mortality [RR (95% CI) (I₂)]		CVD events [RR (95% CI) (I₂)]
	HD patients	Non-HD patients	HD patients	Non-HD patients	HD patients	Non-HD patients
cIMT^a	1.08 (1.00–1.17) (I²: 68%)	NA	1.29 (1.14–1.47) (I²: 0%)	NA	NA	NA
CAC^b	2.51 (1.66–3.79) (I²: 5.7%)	NA	NA	NA	3.77 (2.16–6.58) (I²: 20.2%)	4.02 (1.57–10.29) (I²: 63.4%)
PWV^b	5.34 (3.01–9.47) (I²: 0%)	2.52 (1.40–4.55) (I²: 62.6%)	8.55 (4.37–94.39) (I²: 0%)	NA	NA	NA
PWV^a	1.25 (1.17–1.34) (I²: 0%)	NA	1.24 (1.16–1.34) (I²: 15.5%)	NA	NA	NA

	All-cause mortality [RR (95% CI) (I₂)]		CVD mortality [RR (95% CI) (I₂)]		CVD events [RR (95% CI) (I₂)]
	HD patients	Non-HD patients	HD patients	Non-HD patients	HD patients	Non-HD patients
cIMT^a	1.08 (1.00–1.17) (I²: 68%)	NA	1.29 (1.14–1.47) (I²: 0%)	NA	NA	NA
CAC^b	2.51 (1.66–3.79) (I²: 5.7%)	NA	NA	NA	3.77 (2.16–6.58) (I²: 20.2%)	4.02 (1.57–10.29) (I²: 63.4%)
PWV^b	5.34 (3.01–9.47) (I²: 0%)	2.52 (1.40–4.55) (I²: 62.6%)	8.55 (4.37–94.39) (I²: 0%)	NA	NA	NA
PWV^a	1.25 (1.17–1.34) (I²: 0%)	NA	1.24 (1.16–1.34) (I²: 15.5%)	NA	NA	NA

Per unit increase analysis.

Cut-off analysis.

NA, not enough data available to perform meta-analysis.

Table 4.

Open in new tab

Meta-analysis results for all three outcomes, shown separately for HD and non-HD patients

	All-cause mortality [RR (95% CI) (I₂)]		CVD mortality [RR (95% CI) (I₂)]		CVD events [RR (95% CI) (I₂)]
	HD patients	Non-HD patients	HD patients	Non-HD patients	HD patients	Non-HD patients
cIMT^a	1.08 (1.00–1.17) (I²: 68%)	NA	1.29 (1.14–1.47) (I²: 0%)	NA	NA	NA
CAC^b	2.51 (1.66–3.79) (I²: 5.7%)	NA	NA	NA	3.77 (2.16–6.58) (I²: 20.2%)	4.02 (1.57–10.29) (I²: 63.4%)
PWV^b	5.34 (3.01–9.47) (I²: 0%)	2.52 (1.40–4.55) (I²: 62.6%)	8.55 (4.37–94.39) (I²: 0%)	NA	NA	NA
PWV^a	1.25 (1.17–1.34) (I²: 0%)	NA	1.24 (1.16–1.34) (I²: 15.5%)	NA	NA	NA

	All-cause mortality [RR (95% CI) (I₂)]		CVD mortality [RR (95% CI) (I₂)]		CVD events [RR (95% CI) (I₂)]
	HD patients	Non-HD patients	HD patients	Non-HD patients	HD patients	Non-HD patients
cIMT^a	1.08 (1.00–1.17) (I²: 68%)	NA	1.29 (1.14–1.47) (I²: 0%)	NA	NA	NA
CAC^b	2.51 (1.66–3.79) (I²: 5.7%)	NA	NA	NA	3.77 (2.16–6.58) (I²: 20.2%)	4.02 (1.57–10.29) (I²: 63.4%)
PWV^b	5.34 (3.01–9.47) (I²: 0%)	2.52 (1.40–4.55) (I²: 62.6%)	8.55 (4.37–94.39) (I²: 0%)	NA	NA	NA
PWV^a	1.25 (1.17–1.34) (I²: 0%)	NA	1.24 (1.16–1.34) (I²: 15.5%)	NA	NA	NA

Per unit increase analysis.

Cut-off analysis.

NA, not enough data available to perform meta-analysis.